Imogen Fitt[email protected]Industry NewsIs the x-ray market set for a post-COVID bounceback?In the wake of COVID-19, the market for general radiography and fluoroscopy systems has experienced a significant shift, with chest x-ray examinations identified as a key tool to diagnose and track the progression of late-stage COVID-19. Imogen Fitt of Signify Research explains why a bounceback in equipment sales could be coming.June 18, 2020Breast3 reasons why growth in the mammography market will slowRevenue in the global market for mammography systems is expected to slow in coming years, according to a new report by U.K. market research firm Signify Research. Why are we seeing this deceleration? Signify analyst Imogen Fitt shares three reasons.August 1, 2019Page 1 of 1Top StoriesMolecular ImagingSNMMI: Dual-targeting radioligand therapy safe for several cancersA new "dual-targeting" radioligand therapy has been shown to be safe and effective in humans.Molecular ImagingVideo from SNMMI: Phillip Kuo on new Alzheimer’s disease imaging guidelinesMolecular ImagingSNMMI: Dual PET/MRI technique could help manage primary aldosteronismMolecular ImagingSNMMI: Retreatment with Lu-177 PSMA-617 shows promise in mCRPC patientsSponsor ContentJoin Us June 26 at 12 Noon ET for a FREE webinar!
